Filtry
Prognostic and predictive molecular factors in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors (NV15-34678A)
inhibitors (TKI) sunitinib and pazopanib. Primary or secondary resistance to the TKIs to progression in patients with mRCC treated with sunitinib and pazopanib. In addition......
FD - Onkologie a hematologie
- 2015 - 2018 •
- 9 007 tis. Kč •
- 8 747 tis. Kč •
- MZ
Řešení projektu: 1. 5. 2015 - 31. 12. 2018
Uznané náklady
Podpora ze státního rozpočtu (97%)
Poskytovatel: Ministerstvo zdravotnictví
Lysosomal sequestration of tyrosine kinase inhibitors and drug resistance in cancer cells (GA17-16614S)
Targeted cancer therapy utilises rationally designed drugs that interfere with specific molecules essential for proliferation and survival of malignant cells. Tyrosine kinase inhibitors (TKIs) can be given as an example of targeted therapy that broug...
FR - Farmakologie a lékárnická chemie
- 2017 - 2020 •
- 5 018 tis. Kč •
- 4 948 tis. Kč •
- GA ČR
Řešení projektu: 1. 1. 2017 - 11. 12. 2020
Uznané náklady
Podpora ze státního rozpočtu (99%)
Poskytovatel: Grantová agentura České republiky
- 1 - 2 z 2